Known targets — ChEMBL curated mechanism
ACHECHKACHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGHRH2OPRM1
The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1978899 | 0.95 | — | — | |
| Ammonia Solution, Strong SCHEMBL28208732 | 0.91 | — | — | |
| Hydrochloric Acid SCHEMBL4474978 | 0.91 | — | — | |
| Trimethylammonium SCHEMBL28826339 | 0.84 | BBOX1 (0.32) | — | |
| Bromide SCHEMBL1672847 | 0.82 | — | — | |
| Bromide SCHEMBL27986213 | 0.78 | — | — | |
| Hydrochloric Acid SCHEMBL15916954 | 0.78 | — | — | |
| Bromide SCHEMBL5498077 | 0.78 | KDM4E (0.40) | — | |
| Hexadecane SCHEMBL28095398 | 0.78 | TSHR (0.53) | — | |
| SCHEMBL28095167 | 0.78 | TSHR (0.53) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104884198-B | The method for preparing the hollow metal nanometer particle being supported on carrier | LG化学株式会社 | 2017-11-17 | — | — | CN | claimed |
| CN-103857484-B | The method preparing hollow metal nanometer particle and the hollow metal nanometer particle prepared by the method | LG化学株式会社 | 2016-06-08 | — | — | CN | claimed |
| CN-104884198-A | Method for manufacturing hollow metal nanoparticle supported by support body | LG CHEMICAL LTD | 2015-09-02 | — | — | CN | claimed |
| CN-103857484-A | Method for manufacturing hollow metal nanoparticles, and hollow metal nanoparticles manufactured thereby | LG CHEMICAL LTD | 2014-06-11 | — | — | CN | claimed |
| CN-101879140-A | The nanoparticle and the sustained release compositions that comprise aryl-heterocyclic compounds | ELAN PHARMA INT LTD | 2010-11-10 | — | — | CN | claimed |
| CN-101484170-A | Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone | ELAN PHARMA INT LTD (IE) | 2009-07-15 | — | — | CN | claimed |
| CN-101484169-A | Compositions comprising nanoparticulate meloxicam and controlled release hydrocodone | ELAN PHARMA INT LTD (IE) | 2009-07-15 | — | — | CN | claimed |
| CN-101426477-A | Nanoparticulate carvedilol formulations | ELAN PHARMA INT LTD (IE) | 2009-05-06 | — | — | CN | claimed |
| EP-1651189-B1 | NOVEL METAXALONE COMPOSITIONS | ELAN PHARMA INT LTD (IE) | 2008-12-03 | — | — | EP | claimed |
| CN-101309669-A | Compositions of lipoxygenase inhibitors | BAXTER INT (US) | 2008-11-19 | — | — | CN | claimed |
| CN-101212954-A | Nanoparticulate clopidogrel formulations | ELAN PHARMA INT LTD (IE) | 2008-07-02 | — | — | CN | claimed |
| CN-101198314-A | Nanoparticulate quinazoline derivative formulations | ELAN PHARMA INT LTD (IE) | 2008-06-11 | — | — | CN | claimed |
| CN-101198316-A | Nanoparticulate bisphosphonate compositions | ELAN PHARMA INT LTD (IE) | 2008-06-11 | — | — | CN | claimed |
| CN-101180038-A | Nanoparticulate corticosteroid and antihistamine formulations | ELAN PHARMA INT LTD (IE) | 2008-05-14 | — | — | CN | claimed |
| CN-101175480-A | Nanoparticulate leukotriene receptor antagonist/corticosteroid formulations | ELAN PHARMA INT LTD (IE) | 2008-05-07 | — | — | CN | claimed |
| CN-101175481-A | Injectable compositions of nanoparticulate immunosuppressive compounds | ELAN PHARMA INT LTD (IE) | 2008-05-07 | — | — | CN | claimed |
| CN-101160118-A | Nanoparticulate formulations of docetaxel and analogues thereof | ELAN PHARMA INT LTD (IE) | 2008-04-09 | — | — | CN | claimed |
| EP-1658053-B1 | NOVEL COMPOSITIONS OF SILDENAFIL FREE BASE | ELAN PHARMA INT LTD (IE) | 2008-02-27 | — | — | EP | claimed |
| CN-101132770-A | Nanoparticulate candesartan formulations | ELAN PHARMA INT LTD (IE) | 2008-02-27 | — | — | CN | claimed |
| CN-101090720-A | Nanoparticulate compositions of tubulin inhibitor compounds | BAXTER INT (US) | 2007-12-19 | — | — | CN | claimed |